title: Prevalence of family history of breast, colorectal, prostate, and lung cancer in a population-based study.
abstract: BACKGROUND
  A positive family history is a known risk factor for several cancers; thus, obtaining a thorough family cancer history is essential in cancer risk evaluation and prevention management.
  
  
  METHODS
  The Family Health Study, a telephone survey in Connecticut, was conducted in 2001. A total of 1,019 participants with demographic information and family cancer history were included in this study. Prevalence of a positive family history of breast, colorectal, prostate, and lung cancer for first- and second-degree relatives was estimated. Logistic regression was used to compare prevalence by demographic factors.
  
  
  RESULTS
  A positive family history among first-degree relatives was reported by 10.9% (95% Confidence Interval, CI = 8.8-13.3) of respondents for breast cancer, 5.1% (95% CI = 3.9-6.7) for colorectal cancer, 7.0% (95% CI = 5.2-9.4) for prostate cancer, and 6.4% (95% CI = 4.9-8.3) for lung cancer. The reported prevalence of family history of specific cancers varied by sex, age and race/ethnicity of the respondents.
  
  
  CONCLUSIONS
  Family history prevalence for 4 of the most common adult solid tumors is substantial and the reported prevalence varied by respondent characteristics. Additional studies are needed to evaluate tools to promote accurate reporting of family history of cancer.
authors.affiliation: Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20852, USA. maip@mail.nih.gov
authors.forename: P L
authors.initials: PL
authors.lastname: Mai
authors.forename: L
authors.initials: L
authors.lastname: Wideroff
authors.forename: M H
authors.initials: MH
authors.lastname: Greene
authors.forename: B I
authors.initials: BI
authors.lastname: Graubard
mesh_terms: D000328:Adult; D001943:Breast Neoplasms / Q000453:epidemiology* / Q000235:genetics / Q000517:prevention & control; D015179:Colorectal Neoplasms / Q000453:epidemiology* / Q000235:genetics / Q000517:prevention & control; D005192:Family Health; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D008175:Lung Neoplasms / Q000453:epidemiology* / Q000235:genetics / Q000517:prevention & control; D008297:Male; D008487:Medical History Taking / Q000706:statistics & numerical data*; D008875:Middle Aged; D015995:Prevalence; D011471:Prostatic Neoplasms / Q000453:epidemiology* / Q000235:genetics / Q000517:prevention & control; D012307:Risk Factors; D011795:Surveys and Questionnaires; D014481:United States / Q000453:epidemiology
references.citation: Genet Med. 2006 Jul;8(7):438-42
references.pmid: 16845276
references.citation: J Clin Oncol. 1994 Aug;12(8):1724-36
references.pmid: 8040684
references.citation: Am J Epidemiol. 1999 Mar 1;149(5):454-62
references.pmid: 10067905
references.citation: Cancer. 2005 May 1;103(9):1906-15
references.pmid: 15779016
references.citation: Community Genet. 2008;11(6):331-42
references.pmid: 18690001
references.citation: Stat Methods Med Res. 1996 Sep;5(3):283-310
references.pmid: 8931197
references.citation: Genet Med. 2002 Jul-Aug;4(4):304-10
references.pmid: 12172397
references.citation: Prostate. 2008 Oct 1;68(14):1582-91
references.pmid: 18646000
references.citation: Am J Epidemiol. 1997 Aug 1;146(3):244-8
references.pmid: 9247008
references.citation: CA Cancer J Clin. 2006 Jan-Feb;56(1):11-25; quiz 49-50
references.pmid: 16449183
references.citation: Biometrics. 1999 Jun;55(2):652-9
references.pmid: 11318229
references.citation: Am J Prev Med. 2003 Feb;24(2):128-35
references.pmid: 12568818
references.citation: N Engl J Med. 2004 Nov 25;351(22):2333-6
references.pmid: 15564550
references.citation: Br J Cancer. 1995 Apr;71(4):882-7
references.pmid: 7710959
references.citation: Fam Pract. 1995 Sep;12(3):287-9
references.pmid: 8536831
references.citation: Int J Cancer. 2007 Dec 15;121(12):2748-52
references.pmid: 17724720
references.citation: Int J Cancer. 2001 Apr 1;92(1):144-50
references.pmid: 11279618
references.citation: J Natl Med Assoc. 2008 Jul;100(7):833-9
references.pmid: 18672561
references.citation: Ann Oncol. 2008 Jan;19(1):163-7
references.pmid: 17804474
references.citation: CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
references.pmid: 18287387
references.citation: Am J Epidemiol. 2003 May 1;157(9):792-9
references.pmid: 12727673
references.citation: J Cancer Educ. 2006 Spring;21(1 Suppl):S32-6
references.pmid: 17020499
references.citation: Cancer Epidemiol Biomarkers Prev. 1999 Jul;8(7):635-9
references.pmid: 10428202
references.citation: Am J Prev Med. 2003 Feb;24(2):190-8
references.pmid: 12568826
references.citation: Genet Med. 2006 Sep;8(9):571-5
references.pmid: 16980813
references.citation: Cancer Causes Control. 2008 Feb;19(1):1-12
references.pmid: 17906935
references.citation: J Clin Oncol. 2005 Jan 10;23(2):276-92
references.pmid: 15637391
references.citation: Cancer. 2005 Jul 15;104(2):388-94
references.pmid: 15912495